Thi Ngoc Vy Trinh

Statistics

Publications

Citations

108

H-Index

Active since

1995

Affiliations

Eli Lilly (United States)(Current)

Thi Ngoc Vy Trinh is an author at Eli Lilly (United States) specializing in infectious diseases, immune response assessment, and monoclonal antibodies.

ORCID

Publications per year

1995–2022

Publications

Extraordinary High Rate of HTLV Type II Seropositivity in Intravenous Drug Abusers in South Vietnam

Yoshiko Fukushima, Hidehiro Takahashi, William W. Hall et al. · AIDS Research and Human Retroviruses · 1995 · 48 citations

Life Sciences, Infectious Diseases, Microbiology +13

The anti–SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination

Robert J. Benschop, Jay Tuttle, Lin Zhang et al. · Science Translational Medicine · 2022 · 36 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together

Lin Zhang, Josh Poorbaugh, Michael Dougan et al. · Frontiers in Immunology · 2021 · 24 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

1–3 of 3